How to tap into the world's third-largest Japanese pharmaceutical market?The Korean Pharmaceutical Bio Association and the Embassy of Japan will hold a webinar on their entry strategy on the 28th

Aug 14, 2025

How to tap into the world's third-largest Japanese pharmaceutical market?The Korean Pharmaceutical Bio Association and the Embassy of Japan will hold a webinar on their entry strategy on the 28th



According to a report published by the Korea Health Industry Promotion Agency 'Global BioHealth Industry Market Size', Japan's pharmaceutical market is about $87 billion (W121 trillion), the third largest in the world after the United States and China. Domestic companies have had difficulty entering the market due to Japan's 'Domestic Product Priority', but the opportunity to enter the market seems to be expanding due to the aging population and the rapid increase in demand for bio-healthcare.

The Intellectual Property Specialized Committee of the Korea Pharmaceutical and Bio Association and the Embassy of Japan will jointly hold the 「2nd Pharmaceutical and Bio Company Japanese Market Entry Strategy Webinar" on the 28th.

This webinar is the second event following the '1st Webinar' held on June 26. At that time, it dealt with the current status and prospects of Japan's generic drug industry and patent strategies of global pharmaceutical companies and received great response from the participants.




The second webinar will be held for members of the association that have entered or are planning to enter Japan, as well as officials from the government and related organizations. As a lecture program, Tanaka Yasuko, CEO of S-Cube Co., Ltd., will give a lecture on the theme of 「The Latest Situation of Japan's Drug Patent Strategy - Original vs. Generic Workshop」. CEO Yasuko Tanaka has been in charge of intellectual property practice at global companies such as Pfizer and 3M, and has been working as an expert on intellectual property litigation since establishing a patent office with intellectual property consulting firm S-Cube Inc. in 2014.

Kang Myung-il, the Economic Corporation of the Embassy of Japan, said, `This webinar was designed to be of practical help in establishing an intellectual property strategy for Korean companies to enter the Japanese market. We hope that useful and realistic information will be shared, and we hope that cooperation in the pharmaceutical and bio sectors between Korea and Japan will be further activated" he said.






This article was translated by Naver AI translator.